DK2196545T3 - Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose - Google Patents
Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret scleroseInfo
- Publication number
- DK2196545T3 DK2196545T3 DK10003542.7T DK10003542T DK2196545T3 DK 2196545 T3 DK2196545 T3 DK 2196545T3 DK 10003542 T DK10003542 T DK 10003542T DK 2196545 T3 DK2196545 T3 DK 2196545T3
- Authority
- DK
- Denmark
- Prior art keywords
- disseminated sclerosis
- predicting
- diagnosis
- patients
- procedures
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 230000004043 responsiveness Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003978A EP1826277A1 (en) | 2006-02-27 | 2006-02-27 | Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
| EP07711702A EP1991696B1 (en) | 2006-02-27 | 2007-02-27 | Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2196545T3 true DK2196545T3 (da) | 2012-07-16 |
Family
ID=36658688
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07711702.6T DK1991696T3 (da) | 2006-02-27 | 2007-02-27 | Fremgangsmåde til diagnosticering af et anlæg hos patienter med dissemineret sclerose for modtagelighed for interferonterapi samt til diagnosticering af dissemineret sclerose |
| DK10003542.7T DK2196545T3 (da) | 2006-02-27 | 2007-02-27 | Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07711702.6T DK1991696T3 (da) | 2006-02-27 | 2007-02-27 | Fremgangsmåde til diagnosticering af et anlæg hos patienter med dissemineret sclerose for modtagelighed for interferonterapi samt til diagnosticering af dissemineret sclerose |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8071299B2 (da) |
| EP (4) | EP1826277A1 (da) |
| AT (2) | ATE466959T1 (da) |
| DE (1) | DE602007006284D1 (da) |
| DK (2) | DK1991696T3 (da) |
| SI (1) | SI2196545T1 (da) |
| WO (1) | WO2007096197A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2207902A1 (en) * | 2007-11-09 | 2010-07-21 | INSERM (Institut National de la Santé et de la Recherche Medicale) | A method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon |
| AU2009273277A1 (en) * | 2008-07-24 | 2010-01-28 | Merck Serono S.A. | Use of genetic markers for identifying the response to interferon treatment in Multiple Sclerosis patients |
| WO2011117267A1 (en) * | 2010-03-24 | 2011-09-29 | Merck Serono Sa | Cladribine treatment of multiple sclerosis in patient groups defined by genotype |
| EP2380992A1 (en) * | 2010-04-21 | 2011-10-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for predicting an antibody response to interfer on therapy in multiple sclerosis patients |
| WO2018140156A1 (en) * | 2017-01-27 | 2018-08-02 | Orig3N, Inc. | Systems and methods for determining and presenting purchase recommendations based on personal genetic profiles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1114998A3 (en) | 1999-10-28 | 2001-08-22 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for determining the success rate of treatment of multiple sclerosis |
| WO2003014319A2 (en) | 2001-08-07 | 2003-02-20 | Genaissance Pharmaceuticals, Inc. | Polymorphisms associated with multiple sclerosis |
| SE0103423D0 (sv) | 2001-10-12 | 2001-10-12 | Astrazeneca Ab | Polymorphism |
| GB0307914D0 (en) | 2003-04-07 | 2003-05-14 | Univ Dundee | Cytochrome p450 |
| EP1706507A4 (en) * | 2003-11-26 | 2008-02-20 | Univ Ohio State Res Found | THE RISK AND PROGRESSION OF MULTIPLE SCLEROSIS PREDICTING POLYMORPHS CD24 GENOTYPES |
-
2006
- 2006-02-27 EP EP06003978A patent/EP1826277A1/en not_active Withdrawn
-
2007
- 2007-02-27 AT AT07711702T patent/ATE466959T1/de not_active IP Right Cessation
- 2007-02-27 EP EP07711702A patent/EP1991696B1/en not_active Not-in-force
- 2007-02-27 DK DK07711702.6T patent/DK1991696T3/da active
- 2007-02-27 AT AT10003542T patent/ATE557102T1/de active
- 2007-02-27 SI SI200730969T patent/SI2196545T1/sl unknown
- 2007-02-27 DE DE602007006284T patent/DE602007006284D1/de active Active
- 2007-02-27 DK DK10003542.7T patent/DK2196545T3/da active
- 2007-02-27 EP EP10003542A patent/EP2196545B1/en not_active Not-in-force
- 2007-02-27 WO PCT/EP2007/001689 patent/WO2007096197A2/en not_active Ceased
- 2007-02-27 US US12/280,665 patent/US8071299B2/en not_active Expired - Fee Related
- 2007-02-27 EP EP10003543A patent/EP2196546B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| DE602007006284D1 (de) | 2010-06-17 |
| ATE557102T1 (de) | 2012-05-15 |
| WO2007096197A3 (en) | 2007-10-18 |
| EP1826277A1 (en) | 2007-08-29 |
| US8071299B2 (en) | 2011-12-06 |
| DK1991696T3 (da) | 2010-08-30 |
| EP2196546B1 (en) | 2013-02-27 |
| WO2007096197A2 (en) | 2007-08-30 |
| EP2196546A1 (en) | 2010-06-16 |
| EP2196545A1 (en) | 2010-06-16 |
| SI2196545T1 (sl) | 2012-09-28 |
| ATE466959T1 (de) | 2010-05-15 |
| US20090186773A1 (en) | 2009-07-23 |
| EP1991696A2 (en) | 2008-11-19 |
| EP1991696B1 (en) | 2010-05-05 |
| EP2196545B1 (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007114901A3 (en) | Method for diagnosing adhd and related behavioral disorders | |
| EP2083897A4 (en) | PATIENT INTERFACE SYSTEMS | |
| DK1984357T3 (da) | 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme | |
| WO2007005623A3 (en) | System and method for providing individually tailored health-promoting information | |
| DK2046819T3 (da) | Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet | |
| WO2010101641A3 (en) | Galvanic vestibular stimulation system and method of use for simulation, directional cueing, and alleviating motion-related sickness | |
| DE602005001521D1 (de) | Spritzenset für Ballonkatheter | |
| EP2001534A4 (en) | SYSTEM FOR MONITORING THE COMPLIANCE OF MEDICINAL DOSES | |
| EP1802362A4 (en) | NONMAGNETIC MEDICAL INFUSION DEVICE | |
| EP1664752A4 (en) | PATIENT POSITIONING SYSTEM FOR RADIOTHERAPY SYSTEM | |
| EP2273918A4 (en) | METHODS, SYSTEMS AND DEVICES FOR DETECTING AND DIAGNOSIS OF HEART DISEASES AND DRESSES | |
| EP2061907A4 (en) | Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181 | |
| EP2211689A4 (en) | VOICE CONTROLLED DASHBOARD WITH CLINICAL INFORMATION | |
| DK1899878T3 (da) | Medicinsk behandlingssystem med en indretning til tilvejebringelse af patientrelaterede data | |
| DE602005015418D1 (de) | Überwachungssystem für den menschlichen körper | |
| ATE375518T1 (de) | Diagnoseverfahren für erkrankungen unter verwendung von copeptin | |
| DK2196545T3 (da) | Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose | |
| ITMO20050159A1 (it) | Sistema per il controllo dell'umidita'. | |
| DK1817282T3 (da) | Til behandling af respiratoriske sygdomme egnede phenoxy derivater | |
| LTPA2018503I1 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
| FI20050263A0 (fi) | Hissiryhmä ja menetelmä hissiryhmän ohjaamiseksi | |
| DK2422786T3 (da) | Nye lægemiddelkombinationer til behandling af luftvejssygdomme | |
| WO2007100980A3 (en) | Electronic contracting | |
| DE602005007576D1 (de) | Behandlungsvorrichtung für ein endoskop | |
| WO2005079284A3 (en) | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |